Company Filing History:
Years Active: 2023
Title: Tuanjie Wang: Innovator in Pharmaceutical Chemistry
Introduction
Tuanjie Wang is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating cardiovascular and cerebrovascular diseases.
Latest Patents
Wang holds a patent for "Salts formed by 2-(1-acyloxy-n-pentyl) benzoic acid and basic amino acid or aminoguanidine, and preparation method and application thereof." This patent discloses salts formed by the aforementioned compounds, along with a preparation method and their applications in pharmaceutical formulations. The compound exhibits excellent water solubility, stability in aqueous solutions, and favorable pharmacokinetic properties. It demonstrates significant anti-platelet aggregation, anti-thrombosis, and neuroprotective activity, making it a promising candidate for drug development aimed at preventing ischemic conditions.
Career Highlights
Wang is associated with Jiangsu Kanion Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical innovations. His work has led to the creation of compounds that show improved efficacy and lower toxicity compared to existing treatments.
Collaborations
Wang has collaborated with notable colleagues, including Yihua Zhang and Wei Xiao, contributing to a dynamic research environment that fosters innovation in drug development.
Conclusion
Tuanjie Wang's contributions to pharmaceutical chemistry highlight his role as an innovator in the field. His patented work on novel compounds showcases the potential for advancements in treating serious health conditions.